Sinar100 ml

Sinar is a traditional Unani (herbal) syrup formulation. Its use is based on long-standing traditional practice and anecdotal clinical experience rather than robust modern randomized clinical trials; no formal regulatory (e.g., FDA-type) approved indication exists for Sinar.

Traditional/adjunct uses

• Symptomatic relief of mild digestive discomfort (e.g., bloating, indigestion, dyspepsia)
• Support for reduced or poor appetite
• General supportive care for liver and digestive wellness as part of traditional Unani medicine practice

Sinar is not a substitute for medical evaluation and treatment of persistent, worsening, or severe digestive or liver-related symptoms (e.g., jaundice, persistent vomiting, severe abdominal pain, unexplained weight loss); such symptoms warrant prompt medical attention rather than reliance on Sinar alone.

Sharbat Deenar is a compound Unani herbal syrup. Its exact formulation and standardized composition can vary by manufacturer, but it is traditionally prepared from a combination of botanical/herbal ingredients (a "Deenar" compound) historically used in Unani medicine to support digestive and hepatic function, combined in a sugar-based syrup ("Sharbat") base. Patients should check the specific product label of the Sharbat Deenar formulation they are using for the exact list of herbal ingredients and excipients, as these are not standardized across all manufacturers.

Sinar is a traditional oral herbal syrup used within Unani medicine. "Sharbat" is the Persian/Unani term for a sweetened syrup preparation, and "Deenar" (also transliterated "Dinar") refers to a traditional compound herbal formulation historically associated with support of liver and digestive health. Sinar is classified as a traditional/herbal medicine rather than a single chemically-defined pharmaceutical entity, and its therapeutic claims are based on traditional use rather than modern controlled clinical trial evidence.

Sinar belongs to the traditional Unani (herbal/complementary) medicine class of hepato-digestive tonics, sometimes broadly grouped with other traditional digestive and liver-supportive syrup preparations.

As a multi-herb traditional formulation, the precise pharmacological mechanism of Sharbat Deenar has not been established through modern pharmacokinetic or pharmacodynamic studies. Traditional Unani medicine attributes digestive and hepato-supportive properties to the herbal constituents of Sharbat Deenar, which are believed, per traditional theory, to stimulate appetite and support normal digestive and liver function. These effects have not been confirmed through controlled human pharmacological trials, and no validated absorption, metabolism, or excretion data exist for Sharbat Deenar as a whole formulation.

Sinar is intended for oral use only. It is typically diluted with water before consumption and taken after meals. Shake well before use if directed on the label. Do not exceed the dose recommended on the product label or by a treating physician/Unani practitioner.

Formal drug-interaction studies have not been conducted for Sinar as a compound herbal formulation. As with other sugar-based herbal syrups, caution is advised when using Sinar together with antidiabetic medications, since the sugar content may affect blood glucose control. Patients on other prescription medications, particularly for chronic liver disease, diabetes, or gastrointestinal conditions, should inform their physician before using Sinar to avoid any unrecognized herb-drug interaction.

Reported adverse effects with Sinar are not well characterized in controlled studies, consistent with most traditional herbal formulations. Potential effects that have been reported anecdotally with similar Unani digestive syrups include:

• Mild gastrointestinal upset (e.g., nausea, loose stools) in some individuals
• Allergic reactions (e.g., skin rash, itching) in individuals sensitive to specific herbal components

Patients should stop Sinar and seek medical advice if they experience any unexpected or persistent adverse reaction.

Sinar is not recommended for use during pregnancy or while breastfeeding. Because Sinar is a multi-herb traditional formulation, adequate safety data in pregnant or lactating women is not available, and potential risk to the fetus or infant cannot be excluded. Pregnant or breastfeeding women should avoid Sinar unless specifically advised and supervised by a qualified physician or Unani practitioner who has weighed potential benefit against potential risk.

Sinar should be used with caution in people with diabetes mellitus, as syrup ("Sharbat") formulations commonly contain sugar; blood glucose should be monitored in diabetic patients using Sinar, and a sugar-free alternative or physician guidance should be sought if needed.

The standardized composition and dosing of Sinar can vary between manufacturers, since it is a traditional compound preparation rather than a single standardized chemical entity. Sinar should be used only under the guidance of a qualified Unani practitioner or physician, and not as a substitute for standard medical evaluation.

Persistent, worsening, or severe digestive or liver-related symptoms, such as jaundice (yellowing of skin/eyes), severe abdominal pain, or persistent vomiting, warrant prompt medical evaluation and should not be managed by relying on Sinar alone.

Specific data on overdose with Sinar are not available. As with any herbal syrup, taking substantially more than the recommended dose of Sinar could theoretically increase the risk of gastrointestinal upset or other adverse effects, and in diabetic individuals, excess intake of the sugar-based syrup could affect blood glucose control. If overdose or accidental ingestion of a large amount of Sinar is suspected, especially in a child, seek immediate medical attention or contact a poison control center/emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Children: Safety and effective dosing of Sinar in children have not been formally established; use only under the guidance of a qualified pediatrician or Unani practitioner.

Elderly: No specific dose adjustment data exist for Sinar in elderly patients; elderly patients with diabetes or chronic liver disease should use Sinar with caution and physician oversight (see Precautions).

Renal/Hepatic impairment: No formal studies have evaluated the use of Sinar in patients with renal or hepatic impairment; such patients should consult a physician before using Sinar, particularly since it is traditionally marketed for liver-supportive use.

Pregnancy and breastfeeding: See Pregnancy and Lactation section; use of Sinar is not recommended.

There is no standardized, clinically validated duration of treatment for Sinar. It is traditionally used for short-term symptomatic relief of digestive discomfort. If symptoms do not improve within a few days of using Sinar, or if they worsen, use should be stopped and a physician consulted rather than continuing Sinar long-term without medical supervision.

Sharbat Deenar is classified as a traditional Unani herbal syrup (a compound hepato-digestive tonic), not a single-molecule pharmaceutical drug class.

The precise mode of action of Sharbat Deenar has not been scientifically established. Traditional Unani medicine theory holds that the herbal constituents of Sharbat Deenar act together to stimulate digestion, support appetite, and provide general hepato-digestive support, but this has not been confirmed by modern pharmacological research.

Safety and efficacy of Sinar in pediatric patients have not been established through controlled clinical studies. If a qualified pediatrician or Unani practitioner determines that Sinar may be appropriate for a child, it should be used only at a practitioner-directed dose and under medical supervision, not self-administered by caregivers without guidance.